A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose

Drug and Alcohol Dependence

Volumn 163, Issue , 2016, Pages 40-47

  Bohnert, Amy S B ^a,b,c   Bonar, Erin E ^a   Cunningham, Rebecca ^a,c,d   Greenwald, Mark K ^e   Thomas, Laura ^a,b   Chermack, Stephen ^a,b   Blow, Frederic C ^a,b   Walton, Maureen ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral intervention; Overdose; Pain; Prescription opioids

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; BEHAVIOR ASSESSMENT; CONTROLLED STUDY; DRUG MISUSE; DRUG OVERDOSE; EMERGENCY WARD; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATIONAL INTERVIEWING; PATIENT ASSESSMENT; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TREATMENT RESPONSE; EARLY INTERVENTION; HIGH RISK BEHAVIOR; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PILOT STUDY; PRESCRIPTION DRUG MISUSE; PROCEDURES; PSYCHOLOGY; SELF REPORT;

ADULT; ANALGESICS, OPIOID; DRUG OVERDOSE; EARLY MEDICAL INTERVENTION; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; OPIOID-RELATED DISORDERS; PILOT PROJECTS; PRESCRIPTION DRUG MISUSE; RISK FACTORS; RISK-TAKING; SELF REPORT;

EID: 84962565280     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.03.018     Document Type: Article

References (41)

1. Albert S., Brason F.W., 2nd Sanford C.K., Dasgupta N., Graham J., Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011, 12(Suppl. 2):S77-S85.
2. Ashrafioun L., Bohnert A.S., Jannausch M., Ilgen M.A. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. J. Subst. Abuse Treat. 2015, 55:15-20.
3. Beck F., Guignard R., Legleye S. Does computer survey technology improve reports on alcohol and illicit drug use in the general population? A comparison between two surveys with different data collection modes in France. PLoS One 2014, 9:e85810.
4. Bernstein E., Topp D., Shaw E., Girard C., Pressman K., Woolcock E., Bernstein J. A preliminary report of knowledge translation: lessons from taking screening and brief intervention techniques from the research setting into regional systems of care. Acad. Emerg. Med. 2009, 16:1225-1233.
5. Bertholet N., Gaume J., Faouzi M., Gmel G., Daeppen J.B. Predictive value of readiness, importance, and confidence in ability to change drinking and smoking. BMC Public Health 2012, 12:708.
6. Bohnert A.S., Fudalej S., Ilgen M.A. Increasing poisoning mortality rates in the United States, 1999-2006. Public Health Rep. 2010, 125:542-547.
7. Booth R.E., Lehman W.E., Latkin C.A., Dvoryak S., Brewster J.T., Royer M.S., Sinitsyna L. Individual and network interventions with injection drug users in 5 Ukraine cities. Am. J. Public Health 2011, 101:336-343.
8. Butler S.F., Budman S.H., Fernandez K.C., Houle B., Benoit C., Katz N., Jamison R.N. Development and validation of the current opioid misuse measure. Pain 2007, 130:144-156.
9. Calcaterra S., Glanz J., Binswanger I.A. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013, 131:263-270.
10. Cantrill S.V., Brown M.D., Carlisle R.J., Delaney K.A., Hays D.P., Nelson L.S., O'Connor R.E., Papa A., Sporer K.A., Todd K.H., Whitson R.R. American College of Emergency Physicians Opioid Guideline Writing Panel, 2012. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Ann. Emerg. Med. 2012, 60:499-525.
11. Centers for Disease Control and Prevention, 2014. Web-based Injury Statistics Query and Reporting System. Available at: . (accessed 19.06.14.). http://www.cdc.gov/injury/wisqars/index.htm.
12. Cherpitel C.J. Changes in substance use associated with emergency room and primary care services utilization in the United States general population: 1995-2000. Am. J. Drug Alcohol Abuse 2003, 29:789-802.
13. Coffin P.O., Sullivan S.D. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann. Intern. Med. 2013, 158:1-9.
14. Coffin P.O., Tracy M., Bucciarelli A., Ompad D., Vlahov D., Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad. Emerg. Med. 2007, 14:616-623.
15. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
16. Cone E.J., Fant R.V., Rohay J.M., Caplan Y.H., Ballina M., Reder R.F., Haddox J.D. Oxycodone involvement in drug abuse deaths: II. Evidence for toxic multiple drug-drug interactions. J. Anal. Toxicol 2004, 28:616-624.
17. Cunningham R., Walton M.A., Maio R.F., Blow F.C., Weber J.E., Mirel L. Violence and substance use among an injured emergency department population. Acad. Emerg. Med. 2003, 10:764-775.
18. Doe-Simkins M., Walley A.Y., Epstein A., Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am. J. Public Health 2009, 99:788-791.
19. Gutierrez-Cebollada J., de la Torre R., Ortuno J., Garces J.M., Cami J. Psychotropic drug consumption and other factors associated with heroin overdose. Drug Alcohol Depend. 1994, 35:169-174.
20. Haegerich T.M., Paulozzi L.J., Manns B.J., Jones C.M. What we know, and don't know: about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014, 145:34-47.
21. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
22. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res. Mon. 1997, 167:17-36.
23. Health and Human Services, HHS Takes Strong Steps to Address Opioid-drug Related Overdose Death and Dependence 202-690-6343 2015, http://www.hhs.gov/news/press/2015pres/03/20150326a.html.
24. Hettema J., Steele J., Miller W.R. Motivational interviewing. Annu. Rev. Clin. Psychol. 2005, 1:91-111.
25. Hingson R., Compton W.M. Screening and brief intervention and referral to treatment for drug use in primary care: back to the drawing board. JAMA 2014, 312:488-489.
26. Miller W.R., Rollnick S. Motivational Interviewing: Helping People Change 2013, The Guilford Press, New York, N.Y. third edition.
27. Miller W.R., Rose G.S. Towards a theory of motivational interviewing. Am. Psychol. 2009, 64:527-537.
28. Murphy M.K., Bijur P.E., Rosenbloom D., Bernstein S.L., Gallagher E.J. Feasibility of a computer-assisted alcohol SBIRT program in an urban emergency department: patient and research staff perspectives. Addict. Sci. Clin. Pract. 2013, 8:2.
29. O'Donnell A., Wallace P., Kaner E. From efficacy to effectiveness and beyond: what next for brief interventions in primary care?. Front. Psychiatry 2014, 5:113.
30. Office of National Drug Control Policy, 2011. Epidemic: Responding to America's Prescription Drug Abuse Crisis. Washington, D.C.
31. Park T.W., Saitz R., Ganoczy D., Ilgen M.A., Bohnert A.S. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015, 350:h2698.
32. Paulozzi L.J., Weisler R.H., Patkar A.A. A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J. Clin. Psychiatry 2011, 72:589-592.
33. Paulozzi L.J., Kilbourne E.M., Shah N.G., Nolte K.B., Desai H.A., Landen M.G., Harvey W., Loring L.D. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012, 13:87-895.
34. Resnicow K., Rollnick S. Motivational interviewing in health promotion and behavioral medicine. Handbook of Motivational Counseling: Goal-Based Approaches to Assessment and Intervention with Addiction 2011, John Wiley & Sons, New York. 2nd ed. W.M. Cox, E. Klinger (Eds.).
35. Strang J., Manning V., Mayet S., Best D., Titherington E., Santana L., Offor E., Semmler C. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008, 103:1648-1657.
36. Substance Abuse and Mental Health Services Administration, 2013. Drug Abuse Warning Network. Avaiable at: . [Accessed on:. http://www.samhsa.gov/data/DAWN.aspx.
37. WHO ASSIST Working Group, The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction 2002, 97:1183-1194.
38. Walley A.Y., Xuan Z., Hackman H.H., Quinn E., Doe-Simkins M., Sorensen-Alawad A., Ruiz S., Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013, 346:f174.
39. Warner-Smith M., Darke S., Lynskey M., Hall W. Heroin overdose: causes and consequences. Addiction 2001, 96:1113-1125.
40. Werch C.E., Lundstrum R.H., Moore A. Bogus-pipeline effects on self-reported college student drug use problems, and attitudes. Int. J. Addict. 1989, 24:1003-1010.
41. Zahradnik A., Otto C., Crackau B., Lohrmann I., Bischof G., John U., Rumpf H.J. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction 2009, 104:109-117.